fashion -WSS

fashion

author：fashion 2025-09-06 09:10:18 - browse：36558

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — Two days after similar decisions in the U.S. and U.K., regulators in Europe on Friday recommended that the approval of Eli Lilly’s diabetes drug Mounjaro be widened to include obesity.

The ruling from a committee of the European Medicines Agency now goes to the European Commission, which makes the final decision but almost always follows the EMA’s guidance.

Mounjaro, known scientifically as tirzepatide, is one of an emerging class of drugs that target receptors of the GLP-1 hormone, and sometimes other molecules, and that have had dramatic effects on weight loss. Doctors have been prescribing the diabetes drugs off-label for obesity, but having specific authorization could streamline the process of getting the medicines.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： In his State of the Union, Biden takes clear aim at 'Big Pharma'

focus

WSS

Lab trade group sues FDA to halt regulation of lab

First medicine developed to treat MASH expected to be approved soon

Antibiotic resistance nearly killed me, so I'm raising awareness of it

A deep dive into Applied Therapeutics’ data, and questions on Cassava

How to bring more disabled researchers into academia

Focused ultrasound for uterine fibroids: an uphill battle

explore

fashion

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

Amylyx ALS drug failure raises questions and concerns

United colonoscopy coverage change 'may cost lives,' doctors say

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Trump demands the U.S. pay no more for drugs than other countries … again

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Dobbs anniversary: the lost opportunity of abortion as health care

What will save rural psychiatry services? Higher Medicaid payments

Apple is now the first public company to be valued at $3 trillion

With psoriasis trial ahead, Alumis raises $259 million

Wikipedia

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

With psoriasis trial ahead, Alumis raises $259 million

Amylyx ALS drug failure raises questions and concerns

What will save rural psychiatry services? Higher Medicaid payments

Air quality improving but still lags in Black, Hispanic communities

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

hotspot

hotspot

focus

explore